Q3 2022 EARNINGS CALL

PRESENTATION.

SEVENUM, 31 OCTOBER 2022

2

Q3 2022

EARNINGS CALL

LIVE FROM

OUR HEADQUARTERS

IN SEVENUM.

JASPER EENHORST, CFO.

STEFAN FELTENS, CEO.

3

TODAY'S AGENDA.

FINANCIAL

PERFORMANCE.

UPDATE ON BUSINESS

AND STRATEGY.

OUTLOOK

AND GUIDANCE.

4

FINANCIAL PERFORMANCE.

HIGHLIGHTS Q3 2022.

5

SOLID AND SUCCESSFUL QUARTER, FULLY IN LINE WITH THE GUIDANCE PROVIDED AT THE START OF THE YEAR:

  • E-RX:HALF A MILLION REDEEMED E-SCRIPTS TO DATE

PROSPECT OF NATIONWIDE ROLL-OUT NEXT YEAR.

  • STRONG SALES GROWTH AGAIN, WITH CONTINUED

MARKET SHARE GAINS ACROSS ALL GEOGRAPHIES.

Q3 SALES UP 20% YOY (Q2: 15%, Q1: 7%), RESULTING IN 9M TOTAL SALES OF EUR 877M. NON-RX GREW BY 22% IN Q3 (9M 18%).

  • POSITIVE ADJUSTED EBITDA IN Q3.

0.9% ADJ. EBITDA MARGIN FOR ONGOING BUSINESS, UP VS. H1 2.4PP.

  • FAST, SUSTAINED CUSTOMER GROWTH AND HIGH

CUSTOMER SATISFACTION.

ACTIVE CUSTOMER BASE CLOSE TO 9M: UP 1.0M YTD; NPS OF 73.

  • SUSTAINABILITY: DRIVING DE-CARBONISATION.

COMMITTED TO BRINGING EMISSIONS ALONG THE ENTIRE VALUE CHAIN TO NET ZERO.

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Shop Apotheke Europe NV published this content on 31 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 31 October 2022 05:38:09 UTC.